| 中文名称 | 5-(3-氯苯基)-N-(4-(吗啉甲基)苯基)呋喃-2-羧酰胺 |
| 英文名称 | 5-(3-Chlorophenyl)-N-[4-(4-morpholinylmethyl)phenyl]-2-furancarboxamide |
| CAS号 | 638156-11-3 |
| 分子式 | C22H21ClN2O3 |
| 分子量 | 396.87 |
| EINECS号 | 804-083-1 |
| 沸点 | 491.0±45.0 °C(Predicted) |
| 密度 | 1.297±0.06 g/cm3(Predicted) |
| 溶解度 | DMSO:可溶10mg/mL(澄清溶液) |
| 形态 | 粉末 |
| 酸度系数(pKa) | 12.54±0.70(Predicted) |
| 颜色 | 白色至米色 |
| 稳定性 | 可在-20°下的DMSO或乙醇溶液保存长达3个月。 |
| 危险品标志 | Xn |
| 危险类别码 | 22-36 |
| 安全说明 | 26 |
| WGK Germany | 3 |
| Target | Value |
|
PKD2
() | 0.6 μM |
|
PKD3
() | 0.7 μM |
|
PKD1
() | 3.2 μM |
CID 2011756 is an ATP-competitive PKD1 inhibitor, with an IC 50 of 3.2 µM. CID 2011756 decreases the phosphorylation of endogenous PKD1 Ser 916 in LNCaP cancer cells with an EC 50 of 10±0.7 µM. CID 2011756 also has cellular pan-PKD inhibitory effects, with IC 50 s of 0.6±0.1 µM and 0.7±0.2 µM for PKD2 and PKD3, respectively.